Supporting the research and development needs of the transfusion medicine and cellular therapies field is a critical strategic goal of CTS. The CTS R&D group participates in and supports a wide variety of clinical trials and other research studies that are initiated either by CTS or our healthcare partners. These clinical trials are funded by a variety of sources, including: federal, state and international governments as well as academia, philanthropic and non-governmental organizations.